Patient death prompts concerns about clozapine and smoking cessation awareness
A coroner has issued a report following the death of a patient from clozapine toxicity, highlighting the critical need for better awareness regarding how smoking cessation affects drug metabolism. The case underscores a potential gap in clinical guidance regarding the impact of smoking reduction on medication levels.
Why it matters
It highlights a significant patient safety risk where changes in lifestyle habits can lead to fatal drug toxicity if not properly managed by healthcare providers.
A coroner has raised concerns about awareness of the impact of smoking reduction and cessation on clozapine levels, following the death of a patient.
Deborah Lakin, assistant coroner for Worcestershire, wrote to Herefordshire and Worcestershire Health and Care NHS Trust in a ‘ Prevention of future deaths report’ (PFD), published online on 28 July 2026, following the death of Jack Burton, aged 29, in October 2025 from clozapine toxicity.
The coroner wrote: “Mr Burton had been prescribed clozapine for schizophrenia, and he was a smoker, who had been regularly advised that any cessation of smoking would increase clozapine levels. Mr Burton stopped smoking tobacco on or before 4 October 2025. On the evidence it is likely that this led to a fatal increase in clozapine blood levels.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in